Page last updated: 2024-12-10

capsorubin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5281229
CHEBI ID3378
SCHEMBL ID115586
MeSH IDM0109053

Synonyms (23)

Synonym
805vab3l0h ,
unii-805vab3l0h
einecs 207-425-2
LMPR01070048
all-trans-capsorubin
CHEBI:3378
(3s,5r,3's,5'r)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione
(3s,3's,5r,5'r)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione
470-38-2
C08585
capsorubin ,
SCHEMBL115586
28368-02-7
.kappa.,.kappa.-carotene-6,6'-dione, 3,3'-dihydroxy-, (3s,3's,5r,5'r)-
capsorubin, all-trans-
(3s,3's,5r,5'r)-3,3'-dihydroxy-.kappa.,.kappa.-carotene-6,6'-dione
2,4,6,8,10,12,14,16,18-eicosanonaene-1,20-dione, 1,20-bis(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-, (1r,1r,4s,4s)-(all-e)-
3,3'-dihydroxy-k,k-carotene-6,6'-dione
e160 (capsorubin)
(2e,4e,6e,8e,10e,12e,14e,16e,18e)-1,20-bis((1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaene-1,20-dione
Q15633290
DTXSID901018116
AKOS040754968

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of the pepper-specific carotenoids capsanthin and capsorubin from paprika oleoresin is very low."( Incorporation of carotenoids from paprika oleoresin into human chylomicrons.
Martin, HD; Pérez-Gálvez, A; Sies, H; Stahl, W, 2003
)
0.55
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carotenone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
capsanthin and capsorubin biosynthesis27

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (21.05)18.7374
1990's2 (10.53)18.2507
2000's5 (26.32)29.6817
2010's5 (26.32)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.33 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index44.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.76%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]